ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferreira, R.
Right arrow Articles by Boveris, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferreira, R.
Right arrow Articles by Boveris, A.

The Annals of Thoracic Surgery, Vol 48, 77-83, Copyright © 1989 by The Society of Thoracic Surgeons


ARTICLES

Reduction of reperfusion injury with mannitol cardioplegia

R Ferreira, M Burgos, S Llesuy, L Molteni, J Milei, BG Flecha and A Boveris
Department of Cardiovascular Surgery, ECAVI Sanatorio Colegiales, Buenos Aires.

Forty consecutive patients undergoing myocardial revascularization were divided into two equal groups: group 1 received standard cardioplegic solution, and group 2 received a solution containing mannitol, 59.8 mmol/L. In 6 patients in each group, myocardial biopsies were done before ischemia and at the time of reperfusion. Samples were assessed by chemiluminescence to determine oxidative stress and by electron microscopic studies. A significant reduction in atrial arrhythmias was observed in the mannitol group. Chemiluminescence in group 1 showed a photoemission of 37.6 +/- 3.5 cpm/mg of protein x 10(-3) for the preischemia samples and 74.8 +/- 16 cpm/mg of protein x 10(-3) for the reperfusion samples (p less than 0.001). In group 2, the values for chemiluminescence were 37.7 +/- 3.4 cpm/mg of protein x 10(-3) and 40 +/- 6.1 cpm/mg of protein x 10(-3), respectively (p = not significant). Electron microscopic studies showed, for group 1, increased grades of damaged mitochondria in the reperfusion biopsy specimens compared with the preischemia biopsy specimens (p less than 0.01). In group 2, differences for damaged mitochondria were not significant. These results support the hypothesis that mannitol reperfusate significantly reduces myocardial damage in patients undergoing open heart procedures. They also suggest that this protective effect may be in part secondary to the antioxidant property of mannitol, although other mechanisms may have accounted for or contributed to the improved outcome after ischemia.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. Milei, P. Forcada, C. G. Fraga, D. R. Grana, G. Iannelli, M. Chiariello, I. Tritto, and G. Ambrosio
Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion
Cardiovasc Res, March 1, 2007; 73(4): 710 - 719.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Milei, C. G. Fraga, D. R. Grana, R. Ferreira, and G. Ambrosio
Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury
J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2329 - 2336.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
M Larsen, G Webb, S Kennington, N Kelleher, J Sheppard, J Kuo, and J Unsworth-White
Mannitol in cardioplegia as an oxygen free radical scavenger measured by malondialdehyde
Perfusion, January 1, 2002; 17(1): 51 - 55.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. M. Hoenicke, X. Sun, R. G. Strange Jr, and R. J. Damiano Jr
Donor heart preservation with a novel hyperpolarizing solution: Superior protection compared with University of Wisconsin solution
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 746 - 754.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Dunphy, H. W. Richter, M. Azodi, J. Weigand, F. Sadri, F. Sellke, and D. Ely
The effects of mannitol, albumin, and cardioplegia enhancers on 24-h rat heart preservation
Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1591 - H1598.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. J. Toivonen and M. Ahotupa
Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 140 - 147.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. G. Coghlan, W. D. Flitter, S. M. Clutton, R. Panda, R. Daly, G. Wright, C. D. Ilsley, and T. F. Slater
Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 248 - 256.
[Abstract] [Full Text]


Home page
VASC ENDOVASCULAR SURGHome page
T. Ikezawa, N. Nishikimi, and Y. Oba
Lipid Peroxides in the Mechanism of Ischemia/Reperfusion Injury in Skeletal Muscle--Experimental Studies
Vascular and Endovascular Surgery, April 1, 1993; 27(3): 191 - 201.
[Abstract] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
R. Federico Ferreira, J. Milei, S. Llesuy, B. Gonzalez Flecha, H. Hourquebie, L. Molteni, C. de Palma, A. Paganini, L. Scervino, and A. Boveris
Antioxidant Action of Vitamins A and E in Patients Submitted to Coronary Artery Bypass Surgery
Vascular and Endovascular Surgery, April 1, 1991; 25(3): 191 - 195.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The Society of Thoracic Surgeons.